Jones Day Presents: LB&I Examination Strategies: Acknowledgement of Facts IDR
A new bill introduced in Congress last week may limit the ability of branded pharmaceutical companies to extend the period of exclusivity products beyond the term of a single patent. The bill, titled “Terminating the...more